Borna disease virus 1 induces ferroptosis, contributing to lethal encephalitis.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
Oct 2024
Historique:
revised: 03 09 2024
received: 13 06 2024
accepted: 24 09 2024
medline: 7 10 2024
pubmed: 7 10 2024
entrez: 7 10 2024
Statut: ppublish

Résumé

Borna disease virus 1 (BoDV-1) is a neurotropic RNA virus that has been linked to fatal BoDV-1 encephalitis (BVE) in humans. Ferroptosis represents a newly recognized kind of programmed cell death that marked by iron overload and lipid peroxidation. Various viral infections are closely related to ferroptosis. However, the link between BoDV-1 infection and ferroptosis, as well as its role in BVE pathogenesis, remains inadequately understood. Herein, we used primary rat cortical neurons, human microglial HMC3 cells, and Sprague‒Dawley rats as models. BoDV-1 infection induced ferroptosis, as ferroptosis characteristics were detected (iron overload, reactive oxygen species buildup, decreased antioxidant capacity, lipid peroxidation, and mitochondrial damage). Analysis via qRT-PCR and Western blot demonstrated that BoDV-1-induced ferroptosis was mediated through Nrf2/HO-1/SLC7a11/GPX4 antioxidant pathway suppression. Nrf2 downregulation was due to BoDV-1 infection promoting Nrf2 ubiquitination and degradation. Following BoDV-1-induced ferroptosis, the PTGS2/PGE2 signaling pathway was activated, and various intracellular lipid peroxidation products and damage-associated molecular patterns were released, contributing to BVE occurrence and progression. More importantly, inhibiting ferroptosis or the ubiquitin‒proteasome system effectively alleviated BVE. Collectively, these findings demonstrate the interaction between BoDV-1 infection and ferroptosis and reveal BoDV-1-induced ferroptosis as an underlying pathogenic mechanism of BVE.

Identifiants

pubmed: 39370874
doi: 10.1002/jmv.29945
doi:

Substances chimiques

NF-E2-Related Factor 2 0
Reactive Oxygen Species 0
Amino Acid Transport System y+ 0
Cyclooxygenase 2 EC 1.14.99.1
Phospholipid Hydroperoxide Glutathione Peroxidase EC 1.11.1.12
SLC7A11 protein, human 0
Heme Oxygenase-1 EC 1.14.14.18
Nfe2l2 protein, rat 0
Ptgs2 protein, rat EC 1.14.99.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e29945

Subventions

Organisme : Non-Profit Central Research Institute Fund of the Chinese Academy of Medical Sciences
ID : 2019PT320002
Organisme : Natural Science Foundation Project of China
ID : 81820108015
Organisme : Chinese Stroke Association Whole Course Management of Cerebrovascular Disease Sailing Fund
Organisme : Chongqing Science and Health Joint Medical Research Project
ID : 2023CCXM003
Organisme : Special Funding Project of Chongqing Yongchuan District Research Platform
ID : YJSJ202135
Organisme : Graduate Innovation Fund of the Fifth Clinical College of Chongqing Medical University
ID : YJSCX202207

Informations de copyright

© 2024 Wiley Periodicals LLC.

Références

Tang T, Guo Y, Xu X, et al. BoDV‐1 infection induces neuroinflammation by activating the TLR4/MyD88/IRF5 signaling pathway, leading to learning and memory impairment in rats. J Med Virol. 2021;93(11):6163‐6171.
Korn K, Coras R, Bobinger T, et al. Fatal encephalitis associated with borna disease virus 1. N Engl J Med. 2018;379(14):1375‐1377.
Pörtner K, Wilking H, Frank C, et al. Risk factors for Borna disease virus 1 encephalitis in Germany—a case‐control study. Emerg Microbes Infect. 2023;12(1):e2174778.
Bauswein M, Eid E, Eidenschink L, et al. Detection of virus‐specific T cells via ELISpot corroborates early diagnosis in human Borna disease virus 1 (BoDV‐1) encephalitis. Infection. Forthcoming 2024. http://10.1007/s15010-024-02246-5
Ludwig H, Bode L. Borna disease virus: new aspects on infection, disease, diagnosis and epidemiology. Revue Scientifique et Technique de l'OIE. 2000;19(1):259‐288.
Nöske K, Bilzer T, Planz O, Stitz L. Virus‐specific CD4+T cells eliminate borna disease virus from the brain via induction of cytotoxic CD8+T cells. J Virol. 1998;72(5):4387‐4395.
Liesche F, Ruf V, Zoubaa S, et al. The neuropathology of fatal encephalomyelitis in human Borna virus infection. Acta Neuropathol. 2019;138(4):653‐665.
Nobach D, Müller J, Tappe D, et al. Update on immunopathology of bornavirus infections in humans and animals. Adv Virus Res. 2020;107:159‐222.
Sun Y, Chen P, Zhai B, et al. The emerging role of ferroptosis in inflammation. Biomed Pharmacother. 2020;127:110108.
Rochette L, Dogon G, Rigal E, et al. Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci. 2022;24(1):449.
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266‐282.
Yao D, Bao L, Wang S, et al. Isoliquiritigenin alleviates myocardial ischemia‐reperfusion injury by regulating the Nrf2/HO‐1/SLC7a11/GPX4 axis in mice. Free Radic Biol Med. 2024;221:1‐12.
Yan R, Lin B, Jin W, Tang L, Hu S, Cai R. NRF2, a superstar of ferroptosis. Antioxidants. 2023;12(9):1739.
Villeneuve NF, Lau A, Zhang DD. Regulation of the Nrf2–Keap1 antioxidant response by the ubiquitin proteasome system: an insight into Cullin‐Ring ubiquitin ligases. Antioxid Redox Signal. 2010;13(11):1699‐1712.
Luo H. Interplay between the virus and the ubiquitin–proteasome system: molecular mechanism of viral pathogenesis. Curr Opin Microbiol. 2016;17:1‐10.
Jacquemyn J, Ralhan I, Ioannou MS. Driving factors of neuronal ferroptosis. Trends Cell Biol. 2024;34(7):535‐546.
Yan HF, Zou T, Tuo QZ, et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6(1):49.
Zhu W, Li Q, Yin Y, et al. Ferroptosis contributes to JEV‐induced neuronal damage and neuroinflammation. Virol Sin. 2024;39(1):144‐155.
Xu XQ, Xu T, Ji W, et al. Herpes simplex virus 1‐induced ferroptosis contributes to viral encephalitis. mBio. 2023;14(1):e0237022.
Bode L, Dürrwald R, Rantam FA, Ferszt R, Ludwig H. First isolates of infectious human Borna disease virus from patients with mood disorders. Mol Psychiatry. 1996;1(3):200‐212.
Shen X, Xu X, Guo Y, et al. Borna disease virus 1 impairs DNA double‐strand break repair through the ATR/Chk1 signalling pathway, resulting in learning and memory impairment in rats. J Gen Virol. 2022;103(12):001813.
Guo Y, Xu X, Tang T, et al. miR‐505 inhibits replication of Borna disease virus 1 via inhibition of HMGB1‐mediated autophagy. J Gen Virol. 2022;103(1):001713.
Zhang L, Liu S, Zhang L, et al. Real‐time qPCR identifies suitable reference genes for Borna disease virus‐infected rat cortical neurons. Int J Mol Sci. 2014;15(12):21825‐21839.
Marty FH, Bettamin L, Thouard A, et al. Borna disease virus docks on neuronal DNA double‐strand breaks to replicate and dampens neuronal activity. iScience. 2022;25(1):103621.
Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med. 2020;152:175‐185.
Sander WJ, Fourie C, Sabiu S, et al. Reactive oxygen species as potential antiviral targets. Rev Med Virol. 2022;32(1):e2240.
Ahola S, Langer T. Ferroptosis in mitochondrial cardiomyopathy. Trends Cell Biol. 2024;34(2):150‐160.
Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1‐2):317‐331.
Rousset F, Yirmiya E, Nesher S, et al. A conserved family of immune effectors cleaves cellular ATP upon viral infection. Cell. 2023;186(17):3619‐3631.
Choi JY, Byeon HW, Park SO, Uyangaa E, Kim K, Eo SK. Inhibition of NADPH oxidase 2 enhances resistance to viral neuroinflammation by facilitating M1‐polarization of macrophages at the extraneural tissues. J Neuroinflammation. 2024;21(1):115.
Foo J, Bellot G, Pervaiz S, Alonso S. Mitochondria‐mediated oxidative stress during viral infection. TIM. 2022;30(7):679‐692.
Lewandowska J, Kalenik B, Wrzosek A, Szewczyk A. Redox regulation of mitochondrial potassium channels activity. Antioxidants. 2024;13(4):434.
Dodson M, Castro‐Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.
Li X, Shang N, Kang Y, et al. Caffeic acid alleviates cerebral ischemic injury in rats by resisting ferroptosis via Nrf2 signaling pathway. Acta Pharmacol Sin. 2024;45(2):248‐267.
Yang S, Ouyang J, Lu Y, Harypursat V, Chen Y. A dual role of heme oxygenase‐1 in tuberculosis. Front Immunol. 2022;13:842858.
Aglago EK, Cross AJ, Riboli E, et al. Dietary intake of total, heme and non‐heme iron and the risk of colorectal cancer in a European prospective cohort study. Br J Cancer. 2023;128(8):1529‐1540.
Gensluckner S, Wernly B, Datz C, et al. Iron, oxidative stress, and metabolic dysfunction‐associated steatotic liver disease. Antioxidants. 2024;13(2):208.
Chiura T, Mitchell AJ, Grote DL, Khojandi N, Teague RM, Mak PJ. Interactions of azole‐based inhibitors with human heme oxygenase. J Inorg Biochem. 2023;244:112238.
Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599‐620.
Weiss‐Sadan T, Ge M, Hayashi M, et al. NRF2 activation induces NADH‐reductive stress, providing a metabolic vulnerability in lung cancer. Cell Metab. 2023;35(3):487‐503.
Carrow KP, Hamilton HL, Hopps MP, et al. Inhibiting the Keap1/Nrf2 protein‐protein interaction with protein‐like polymers. Adv Mater. 2024;36(21):e2311467.
Tang Q, Wu P, Chen H, Li G. Pleiotropic roles of the ubiquitin‐proteasome system during viral propagation. Life Sci. 2018;207:350‐354.
Tang D, Kroemer G, Kang R. Ferroptosis in immunostimulation and immunosuppression. Immunol Rev. 2024;321(1):199‐210.
Chen Y, Fang ZM, Yi X, Wei X, Jiang DS. The interaction between ferroptosis and inflammatory signaling pathways. Cell Death Dis. 2023;14(3):205.
Lei Y, Li D, Deng J, et al. Metabolomic profiling of three brain regions from a postnatal infected Borna disease virus Hu‐H1 rat model. Metabolomics. 2014;10:484‐495.
Gosztonyi G. Natural and experimental Borna disease virus infection—neuropathology and pathogenetic considerations. APMIS Suppl. 2008;124:53‐57.
Li D, Lei Y, Deng J, et al. Human but not laboratory borna disease virus inhibits proliferation and induces apoptosis in human oligodendrocytes in vitro. PLoS ONE. 2013;8(6):e66623.
Guo Y, He P, Sun L, et al. Full‐length genomic sequencing and characterization of Borna disease virus 1 isolates: lessons in epidemiology. J Med Virol. 2020;92(12):3125‐3137.

Auteurs

Qing Tan (Q)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Hongli Yang (H)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Emergency Medicine, The People's Hospital of Jianyang City, Chengdu, China.

Yong He (Y)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Xia Shen (X)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Lin Sun (L)

Department of Anaesthesia and Pain, The First People's Hospital of Chongqing Liangjiang New Area, Chongqing, China.

Xiaoyan Du (X)

Department of Neurology, The Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
Chongqing Key Laboratory of Cerebrovascular Disease Research, Chongqing, China.

Gangqiang Lin (G)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Na Zhou (N)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Nishi Wang (N)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Qian Zhou (Q)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Dan Liu (D)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Xiaoyan Xu (X)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Libo Zhao (L)

Department of Neurology, The Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
Chongqing Key Laboratory of Cerebrovascular Disease Research, Chongqing, China.

Peng Xie (P)

NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH